(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A10 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A10 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO Slc25a10 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC25A10 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Slc25a10 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC25A10 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A10 mRNA CTD PMID:17942748 17beta-estradiol decreases expression ISO Slc25a10 (Mus musculus) 6480464 Estradiol results in decreased expression of SLC25A10 mRNA CTD PMID:19484750 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC25A10 protein CTD PMID:32145629 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of SLC25A10 protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A10 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A10 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc25a10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A10 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A10 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc25a10 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC25A10 mRNA CTD PMID:21354282 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC25A10 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of SLC25A10 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO Slc25a10 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SLC25A10 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC25A10 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC25A10 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO Slc25a10 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SLC25A10 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO Slc25a10 (Mus musculus) 6480464 Fenretinide results in decreased expression of SLC25A10 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC25A10 mRNA CTD PMID:30047161 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:12376462 acrylamide decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Acrylamide results in decreased expression of SLC25A10 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO SLC25A10 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of SLC25A10 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SLC25A10 mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SLC25A10 mRNA CTD PMID:22100608 and PMID:27153756 aflatoxin B1 decreases expression ISO Slc25a10 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of SLC25A10 mRNA CTD PMID:19770486 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of SLC25A10 mRNA and Glucose results in increased expression of SLC25A10 protein CTD PMID:24349266 all-trans-retinoic acid decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC25A10 mRNA CTD PMID:23724009 amitrole increases expression EXP 6480464 Amitrole results in increased expression of SLC25A10 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC25A10 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of SLC25A10 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO SLC25A10 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC25A10 mRNA CTD PMID:33212167 atrazine decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Atrazine results in decreased expression of SLC25A10 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A10 mRNA CTD PMID:20106945 and PMID:32234424 benzo[a]pyrene decreases expression ISO Slc25a10 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC25A10 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO Slc25a10 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC25A10 mRNA CTD PMID:19770486 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC25A10 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC25A10 mRNA CTD PMID:36041667 bisphenol A increases expression ISO Slc25a10 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC25A10 mRNA CTD PMID:34585602 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC25A10 mRNA CTD PMID:32145629 and PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC25A10 protein CTD PMID:32145629 bisphenol A affects expression ISO SLC25A10 (Homo sapiens) 6480464 bisphenol A affects the expression of SLC25A10 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC25A10 gene CTD PMID:28505145 bisphenol A increases methylation ISO Slc25a10 (Mus musculus) 6480464 bisphenol A results in increased methylation of SLC25A10 promoter CTD PMID:27312807 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC25A10 mRNA CTD PMID:36041667 cadmium atom multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC25A10 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC25A10 mRNA CTD PMID:35301059 chlordecone increases expression ISO Slc25a10 (Mus musculus) 6480464 Chlordecone results in increased expression of SLC25A10 mRNA CTD PMID:33711761 chlorpyrifos increases expression ISO Slc25a10 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC25A10 mRNA CTD PMID:37019170 ciguatoxin CTX1B affects expression ISO Slc25a10 (Mus musculus) 6480464 Ciguatoxins affects the expression of SLC25A10 mRNA CTD PMID:18353800 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SLC25A10 protein CTD PMID:22023808 cisplatin decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Cisplatin results in decreased expression of SLC25A10 mRNA CTD PMID:27392435 clofibrate decreases expression ISO Slc25a10 (Mus musculus) 6480464 Clofibrate results in decreased expression of SLC25A10 mRNA CTD PMID:17585979 clofibrate multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC25A10 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC25A10 mRNA] CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of SLC25A10 mRNA CTD PMID:17602206 copper atom multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC25A10 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC25A10 mRNA CTD PMID:20971185 cyclosporin A decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC25A10 mRNA CTD PMID:20106945 D-glucose increases expression EXP 6480464 Glucose results in increased expression of SLC25A10 mRNA and Glucose results in increased expression of SLC25A10 protein CTD PMID:24349266 dexamethasone multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC25A10 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC25A10 mRNA CTD PMID:29950665 dibutyl phthalate decreases expression ISO Slc25a10 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of SLC25A10 mRNA CTD PMID:17361019 and PMID:21266533 dichloroacetic acid increases expression ISO Slc25a10 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of SLC25A10 mRNA CTD PMID:28962523 dioxygen decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of SLC25A10 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A10 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SLC25A10 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLC25A10 protein CTD PMID:23301498 epoxiconazole decreases expression ISO Slc25a10 (Mus musculus) 6480464 epoxiconazole results in decreased expression of SLC25A10 mRNA CTD PMID:35436446 ethanol affects expression ISO Slc25a10 (Mus musculus) 6480464 Ethanol affects the expression of SLC25A10 mRNA CTD PMID:30319688 formaldehyde decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLC25A10 mRNA CTD PMID:23649840 glucose increases expression EXP 6480464 Glucose results in increased expression of SLC25A10 mRNA and Glucose results in increased expression of SLC25A10 protein CTD PMID:24349266 glutathione multiple interactions EXP 6480464 [SLC25A10 protein co-treated with Glutathione] results in decreased susceptibility to S-(1 more ... CTD PMID:12388626 glutathione increases uptake EXP 6480464 SLC25A10 protein results in increased uptake of Glutathione CTD PMID:12388626 indometacin multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SLC25A10 mRNA CTD PMID:28628672 inulin multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC25A10 mRNA CTD PMID:36331819 isoprenaline decreases expression ISO Slc25a10 (Mus musculus) 6480464 Isoproterenol results in decreased expression of SLC25A10 mRNA CTD PMID:20003209 malonic acid increases uptake EXP 6480464 SLC25A10 protein results in increased uptake of malonic acid CTD PMID:12388626 methimazole increases expression EXP 6480464 Methimazole results in increased expression of SLC25A10 mRNA CTD PMID:30047161 monosodium L-glutamate multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC25A10 mRNA CTD PMID:19001666 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC25A10 mRNA CTD PMID:28659758 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of SLC25A10 mRNA CTD PMID:19638242 N-Nitrosopyrrolidine decreases expression ISO SLC25A10 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of SLC25A10 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO SLC25A10 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of SLC25A10 mRNA CTD PMID:27939613 paracetamol multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC25A10 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC25A10 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC25A10 mRNA CTD PMID:33387578 paracetamol affects expression ISO SLC25A10 (Homo sapiens) 6480464 Acetaminophen affects the expression of SLC25A10 mRNA CTD PMID:25704631 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC25A10 mRNA CTD PMID:21251948 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A10 mRNA more ... CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC25A10 mRNA CTD PMID:28659758 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in decreased expression of SLC25A10 mRNA CTD PMID:12376462 pirinixic acid increases expression ISO Slc25a10 (Mus musculus) 6480464 pirinixic acid results in increased expression of SLC25A10 mRNA CTD PMID:17426115 more ... pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of SLC25A10 mRNA CTD PMID:19162173 progesterone affects expression ISO Slc25a10 (Mus musculus) 6480464 Progesterone affects the expression of SLC25A10 mRNA CTD PMID:17251523 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of SLC25A10 mRNA CTD PMID:30047161 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC25A10 mRNA CTD PMID:28659758 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of SLC25A10 mRNA CTD PMID:15576828 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of SLC25A10 mRNA CTD PMID:25905778 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [SLC25A10 protein co-treated with Glutathione] results in decreased susceptibility to S-(1 and 2-dichlorovinyl)cysteine CTD PMID:12388626 SB 431542 multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A10 mRNA CTD PMID:27188386 sodium arsenite decreases expression ISO SLC25A10 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC25A10 mRNA CTD PMID:25879800 sodium arsenite multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 sodium arsenite promotes the reaction [SLC25A10 protein binds to CAPRIN1 protein] CTD PMID:33939924 sodium arsenite increases expression ISO SLC25A10 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC25A10 mRNA CTD PMID:34032870 sodium fluoride decreases expression ISO Slc25a10 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of SLC25A10 protein CTD PMID:28918527 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of SLC25A10 protein CTD PMID:19634143 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of SLC25A10 protein CTD PMID:16595661 streptozocin multiple interactions EXP 6480464 cobaltiprotoporphyrin inhibits the reaction [Streptozocin results in decreased expression of SLC25A10 protein] more ... CTD PMID:16595661 and PMID:19634143 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of SLC25A10 mRNA CTD PMID:30047161 temozolomide increases expression ISO SLC25A10 (Homo sapiens) 6480464 Temozolomide results in increased expression of SLC25A10 mRNA CTD PMID:31758290 tert-butyl hydroperoxide multiple interactions EXP 6480464 [SLC25A10 protein co-treated with Glutathione] results in decreased susceptibility to tert-Butylhydroperoxide CTD PMID:12388626 tert-butyl hydroperoxide increases expression ISO Slc25a10 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of SLC25A10 mRNA CTD PMID:15003993 tetrachloromethane decreases expression ISO Slc25a10 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC25A10 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A10 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC25A10 mRNA CTD PMID:31150632 tetrahydropalmatine increases expression ISO SLC25A10 (Homo sapiens) 6480464 tetrahydropalmatine results in increased expression of SLC25A10 protein CTD PMID:20109541 thapsigargin decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of SLC25A10 mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC25A10 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO Slc25a10 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC25A10 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO Slc25a10 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC25A10 mRNA CTD PMID:29950665 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of SLC25A10 mRNA CTD PMID:30012374 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of SLC25A10 mRNA CTD PMID:30589522 troglitazone decreases expression ISO SLC25A10 (Homo sapiens) 6480464 troglitazone results in decreased expression of SLC25A10 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO Slc25a10 (Mus musculus) 6480464 trovafloxacin results in decreased expression of SLC25A10 mRNA CTD PMID:35537566 tunicamycin decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of SLC25A10 mRNA CTD PMID:22378314 urethane decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Urethane results in decreased expression of SLC25A10 mRNA CTD PMID:28818685 valproic acid decreases expression ISO SLC25A10 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SLC25A10 mRNA CTD PMID:29154799 valproic acid multiple interactions ISO SLC25A10 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A10 mRNA CTD PMID:27188386 valproic acid increases expression ISO SLC25A10 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC25A10 mRNA CTD PMID:23179753 and PMID:26272509 valproic acid increases methylation ISO SLC25A10 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SLC25A10 gene CTD PMID:29154799 vancomycin increases expression ISO Slc25a10 (Mus musculus) 6480464 Vancomycin results in increased expression of SLC25A10 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC25A10 mRNA CTD PMID:23869203 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC25A10 mRNA CTD PMID:23034163 zidovudine increases expression ISO SLC25A10 (Homo sapiens) 6480464 Zidovudine results in increased expression of SLC25A10 mRNA CTD PMID:24292225